Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Moodys
Johnson and Johnson
AstraZeneca
Deloitte
Harvard Business School
Merck
Cerilliant
Healthtrust

Generated: January 23, 2019

DrugPatentWatch Database Preview

Betamethasone dipropionate; calcipotriene hydrate - Generic Drug Details

« Back to Dashboard

What are the generic sources for betamethasone dipropionate; calcipotriene hydrate and what is the scope of betamethasone dipropionate; calcipotriene hydrate patent protection?

Betamethasone dipropionate; calcipotriene hydrate is the generic ingredient in two branded drugs marketed by Perrigo Israel, Tolmar, and Leo Pharma As, and is included in four NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Betamethasone dipropionate; calcipotriene hydrate has eighty-six patent family members in thirty-one countries.

There are sixty-six drug master file entries for betamethasone dipropionate; calcipotriene hydrate. Three suppliers are listed for this compound.

Pharmacology for betamethasone dipropionate; calcipotriene hydrate

US Patents and Regulatory Information for betamethasone dipropionate; calcipotriene hydrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tolmar CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE betamethasone dipropionate; calcipotriene hydrate OINTMENT;TOPICAL 201615-001 Jan 14, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene hydrate SUSPENSION;TOPICAL 022185-001 May 9, 2008 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene hydrate SUSPENSION;TOPICAL 022185-001 May 9, 2008 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for betamethasone dipropionate; calcipotriene hydrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene hydrate OINTMENT;TOPICAL 021852-001 Jan 9, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene hydrate SUSPENSION;TOPICAL 022185-001 May 9, 2008 ➤ Try a Free Trial ➤ Try a Free Trial
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene hydrate OINTMENT;TOPICAL 021852-001 Jan 9, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Citi
McKinsey
Mallinckrodt
Boehringer Ingelheim
Accenture
Moodys
Chinese Patent Office
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.